The block of ryanodine receptors selectively inhibits fetal myoblast differentiation

Alessandro Pisaniello1, Carlo Serra, Daniela Rossi

  • 1Department of Histology and Medical Embryology, University of Rome 'La Sapienza', 00161 Rome, Italy.

Insights

Ryanodine receptors control skeletal muscle development. Blocking these receptors inhibits fetal myoblast differentiation, suggesting their crucial role in muscle histogenesis and mass development.

Area of Science:

  • Muscle biology
  • Developmental biology
  • Cell signaling

Background:

  • Skeletal muscle development involves complex differentiation and morphogenesis of various myogenic cells.
  • Calcium transients are critical signaling mechanisms in embryogenesis and differentiation.
  • Ryanodine receptors (RyRs) generate calcium transients in mature muscle, but their developmental role is unclear.

Purpose of the Study:

  • Investigate the role of ryanodine receptors (RyRs) in skeletal muscle differentiation and development.
  • Determine if RyR activity is essential for contractile function or developmental processes.
  • Clarify the specific contribution of RyRs to different myogenic cell populations.

Main Methods:

  • Examined RyR expression during limb muscle development (E13 onwards).
  • Assessed RyR expression and activity in various isolated myogenic cell populations in vitro.
  • Utilized ryanodine to block RyR activity and observed effects on myoblast differentiation.

Main Results:

  • RyR expression (types 1 and 3) begins at E13, paralleling skeletal myosin expression.
  • RyRs are expressed and active in somitic, embryonic, fetal myoblasts, and satellite cells in vitro.
  • Ryanodine treatment inhibited fetal myoblast differentiation (sarcomeric myosin, myotube formation) but not other cell types.
  • Inhibition occurred at the transcriptional level of terminal differentiation markers, not commitment factors.

Conclusions:

  • Calcium transients are general regulators of muscle differentiation, but pathways vary among myogenic populations.
  • Ryanodine receptor activity is crucial for fetal myoblast differentiation and secondary fiber formation.
  • RyR-mediated calcium release plays a significant role in mammalian skeletal muscle histogenesis.

Related Concept Videos

Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...